Abstract
Background
The inhalation of flour dust increases the risk of allergic obstructive respiratory disease in bakers. Therefore, flour-induced bronchial asthma is one of the most common work-related respiratory diseases, the symptoms of which often lead to disability.
Methods
Since 2002, 39 patients with flour-induced allergic rhinoconjunctivitis and baker’s asthma have undergone hyposensitization in the author’s department using specific immunotherapy (SIT) with a flour mixture. In addition, 10 cases of treatment failure were treated for a further 5 years with a dual therapy consisting of causal SIT and symptomatic treatment using the anti-IgE antibody omalizumab.
Results
SIT- and dual-treated patients showed a marked improvement in nasal, conjunctival, and bronchial symptoms. No severe local or systemic side effects were observed.
Conclusion
Both SIT and dual therapy represent an effective and well-tolerated treatment option in flour dust-allergic individuals.
Similar content being viewed by others
Abbreviations
- FEV1:
-
Forced expiratory volume in 1 s
- IgE:
-
Immunoglobulin E
- MAE11:
-
Monoclonal mouse antibody
- NPT:
-
Nasal provocation test
- rhuMAb-E25:
-
Humanized, monoclonal anti-IgE antibodies
- SCIT:
-
Subcutaneous immunotherapy
- SIT:
-
Specific immunotherapy
- VAS:
-
Visual analog scales
References
Saak A. Unser täglich Brot … Segen oder Gefährdung? Allergiker. 1993;4:8–11.
Sander I, Raulf-Heimsoth M. Ursachen des Bäckerasthmas auf der Spur. Neue Methoden zur Ermittlung des Sensibilisierungsprofils. IPA J. 2011;2:20–1.
Schönberger A, Mehrtens G, Valentin H, editors. Arbeitsunfall und Berufskrankheit. Rechtliche und Medizinische Grundlagen für Gutachter, Sozialverwaltung, Berater und Gerichte. Berlin: Erich Schmidt; 1993.
Straube M, Szliska C, Schwanitz HJ. Allergene und Irritanzien im Bäckerhandwerk. Allergologie. 1996;19:494–9.
Nahrungsmittel-Kontaktallergie bei Bäckern und Konditoren. Umwelt- und berufsdermatologischer Bulletin, Fa. Asche AG, ed. 1997;67
Quirce S, Diaz-Perales A. Diagnosis and management of grain-induced asthma. Allergy Asthma Immunol Res. 2013;5:348–56.
Nemat K, Henker J. Glutenintoleranz. Weizenallergie, Zöliakie, Glutensensitivität. Arztebl Sachsen. 2014;1:27–9.
Raulf-Heimsoth M, van Kampen V, Kespohl S, Sander I, Merget R, Brüning T. Inhalationsallergien am Arbeitsplatz. Aktuelle Entwicklungen. Bundesgesundheitsblatt. 2012;55:363–72.
Sander I, Raulf-Heimsoth M, Düser M, Flagge A, Czuppon AB, Baur X. Differentiation between cosensitization and cross-reactivity of wheat flour and grass pollen allergens. Int Arch Allergy Immunol. 1997;112:378–85.
Tasman AJ, Witzel A, Simonis B, Sohmen R, Grieshaber R, Heppt W. Prick-Test und nasaler Provokationstest mit individuellen Mehlextrakten bei Bäckerrhinitis. HNO. 1999;47:718–22.
Kniel B, Würth C. Allergien in Zusammenhang mit Backwaren und deren Herstellung – ein Diskussionsbeitrag. Inf Backmittelinst. 1996;22:1–8.
Olivieri M, Biscardo CA, Turri S, Perbellini L. Omalizumab in persistent severe baker’s asthma. Allergy. 2008;63:790–1.
Kanerva L, Vaheri E. Occupational allergic rhinitis in Finland. Int Arch Occup Environ Health. 1993;64:565–8.
Houba R, Doekes G, Heederik D. Occupational respiratory allergy in bakery workers: a review of the literature. Am J Ind Med. 1998;34:529–46.
Baur X, Sander I, Jansen A, Czuppon AB. Are amylases in bakery products and flour potential food allergens? Schweiz Med Wochenschr. 1994;124:846–51.
Fränken J, Ulmer WT, Altmeyer P, Stephan U, Das Bäckerasthma KW. Auslösende Allergene und der Einfluss von Hauptallergenen auf immunmodulatorische Vorgänge in vitro. Allergologie. 1993;16:83–6.
Pahr S, Constantin C, Papadopoulos NG, Giavi S, Mäkelä M, Pelkonen A, et al. α‑Purothionin, a new wheat allergen associated with severe allergy. J Allergy Clin Immunol. 2013;132(4):1000–1003.e4.
Simonis B, Sohmen R, Grün L, Heimbüchel G, Grieshaber R. alpha-Amylase-Exposition bei sensibilisierten und nichtsensibilisierten Bäckern mit obstruktiven allergischen Atemwegserkrankungen. Allergo J. 1998;7:425–30.
Baur X, Sander I. Allergien auf Getreidelebensmittel einschließlich Backmittel, Getreide, Mehl und Brot. Inf Backmittelinst. 1995;49:58–61.
Baur X, Chen Z, Sander I. Isolation and denomination of an important allergen in baking additives: alpha-amylase from Aspergillus oryzae (Asp o II). Clin Exp Allergy. 1994;24:465–70.
Sander I, Rozynek P, Rihs HP, van Kampen V, Chew FT, Lee WS, et al. Multiple wheat flour allergens and cross-reactive carbohydrate determinants bind IgE in baker’s asthma. Allergy. 2011;66:1208–15.
bmi aktuell. Informationen aus dem Backmittelinstitut 2001;2
Ring J, Bachert C, Bauer C‑P, Czech W, editors. Weißbuch Allergie in Deutschland. München: Springer; 2010. pp. 17–9.
Braun E. Mehl, das nicht den Atem nimmt. BGN Akzente. 2011. http://www.bgn.de/464/35532?wc_origin=%2F10331%3Fsk%3D2736%26page%3D&wc_mb=WC.
Vermeidung von Bäckerasthma. In: Arbeits-Sicherheits-Informationen der BGN. ASI 8.80 [vorschriften.portal.bgn.de/9427]
Hytönen M, Sala E. Nasal provocation test in the diagnostics of occupational allergic rhinitis. Rhinology. 1996;34:86–90.
Riechelmann H, Bachert C, Goldschmidt O, Hauswald B, Klimek L, Schlenter WW, et al. Durchführung des nasalen Provokationstests bei Erkrankungen der oberen Atemwege. Allergo J. 2002;11:29–36.
Hauswald B, Yarin YM. Moderne Diagnostik und Therapie der Rhinitis allergica. Laryngorhinootologie. 2015;94:331–45.
Wedi B. Stellenwert und Indikation der SLIT im Vergleich zur SCIT. Hautarzt. 2008;59:537–43.
Kleine-Tebbe J, Fuchs T, Klimek L, Kühr J, Kunkel G, Lepp U, et al. Spezifische Immuntherapie bei IgE vermittelten allergischen Atemwegserkrankungen. Dtsch Arztebl. 2003;100:A 334–A 9.
Mösges R. Is classical immunotherapy dead? Curr Opin Allergy Clin Immunol. 2010;10:167.
Armentia A, Martin-Santos JM, Quintero A, Fernandez A, Barber D, Alonso E, et al. Baker’s asthma: prevalence and evaluation of immunotherapy with a wheat flour extract. Ann Allergy. 1990;65:265–72.
Swaminathan S, Heddle JR. Wheat flour immunotherapy in baker’s asthma. Intern Med J. 2007;37:663–4.
Brown SG, Wiese MD, van Eeden P, Stone SF, Chuter CL, Gunner J, et al. Ultrarush versus semirush initiation of insect venom immunotherapy: a randomized controlled trial. J Allergy Clin Immunol. 2012;130:162–8.
Cirla AM, Lorenzini RA, Cirla PE. Specific immunotherapy and relocation in occupational allergic bakers. G Ital Med Lav Ergon. 2007;29(3 Suppl):443–5.
Pérez Pimiento A, Buesco Fernández A, García LJ, Rodríguez Cabreros MI, et al. Effect of omalizumab treatment in a baker with occupational asthma. J Investig Allergol Clin Immunol. 2008;18:490–1.
Brown R, Turk F, Dale P, Bousquet J. Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma. Allergy. 2007;62:149–53.
Verbruggen K, Van Cauwenberge P, Bachert C. Anti-IgE zur Behandlung der Rhinitis allergica – und der Polyposis nasi? Allergologie. 2007;30:338–54.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
B. Hauswald, M. Cuevas, J. Boxberger and T. Zahnert declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Hauswald, B., Cuevas, M., Boxberger, J. et al. Safe and effective hyposensitization in bakers suffering from year-round allergic rhinoconjunctivitis and allergic bronchial asthma caused by flour dust allergy. Allergo J Int 27, 43–48 (2018). https://doi.org/10.1007/s40629-018-0052-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40629-018-0052-4